N
Centralnervesystemet
Parkinsonisme
Antiparkinsonmidler
Levodopa kombineret med decarboxylasehæmmer
MAO-B-hæmmere
COMT-hæmmere
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
Dopaminagonister
Antikolinerge midler
Amantadin
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
N04BA
Revideret: 20.10.2021
Karen Østergaard (Forfatter),
Dansk Neurologisk Selskab
Tove Henriksen (Referent),
Dansk Selskab for Bevægeforstyrrelser
Indledning | Anvendelsesområder | Behandlingsvejledning | Præparatvalg | Doseringsforslag | Nedsat lever- og/eller nyrefunktion | Kontraindikationer | Forsigtighedsregler | Patientsikkerhed | Bivirkninger | Interaktioner | Graviditet | Amning | Forgiftning | Farmakodynamik | Farmakokinetik | Tilskud | Præparater | Referencer
Der henvises i øvrigt også til Levodopa kombineret med decarboxylasehæmmer og COMT-hæmmere for en oversigt over præparater med indholdsstofferne hver for sig.
For yderligere oplysninger om behandling af Parkinsons sygdom, se antiparkinsonmidler.
Præparater
| Indholdsstof | Navn og firma | Dispform og styrke | Pakning | Pris DDD |
|---|---|---|---|---|
| Carbidopa Entacapon Levodopa |
Lecigon® Nordic Infucare
|
enteralgel 20+5+20 mg/ml | 7 x 47 ml | 550,53 |
| Carbidopa Entacapon Levodopa |
Levocaren Parallelimport
|
filmovertrukne tabletter 75+18,75+200 mg | 150 stk. | 52,85 |
| Carbidopa Entacapon Levodopa |
Levocaren Parallelimport
|
filmovertrukne tabletter 125+31,25+200 mg | 150 stk. | |
| Carbidopa Entacapon Levodopa |
Levocaren Parallelimport
|
filmovertrukne tabletter 175+43,75+200 mg | 150 stk. | |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | 15,45 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 130 stk. | 31,08 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 18,42 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 52,78 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 15,24 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 36,49 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk | 16,77 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 34,02 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk | 12,00 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 13,55 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 16,75 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 130 stk. | 27,55 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 100 stk | 12,20 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 18,37 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 15,56 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 36,51 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. | 16,75 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | 12,02 |
| Carbidopa Entacapon Levodopa |
Pentiro Stada
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 15,66 |
| Carbidopa Entacapon Levodopa |
Pentiro Stada
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 36,70 |
| Carbidopa Entacapon Levodopa |
Pentiro Stada
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 13,56 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 30 stk. | 60,88 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 59,62 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Orifarm) | 14,13 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Paranova) | 38,56 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (2care4) | 18,63 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 48,81 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | 39,75 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 32,54 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 30 stk. | 30,70 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 27,31 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 58,06 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 35,88 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 130 stk. | 20,09 |
Referencer
1563. Stocchi F, Rascol O, Kieburtz K et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010; 68(1):18-27, https://pubmed.ncbi.nlm.nih.gov/20582993/ (Lokaliseret 10. december 2021)
4678. Stoessl AJ. Continuous dopaminergic therapy in Parkinson disease: time to stride back?. Ann Neurol. 2010; 68:3-5, https://www.ncbi.nlm.nih.gov/pubmed/20583222 (Lokaliseret 3. marts 2022)
